SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038414
Filing Date
2023-11-13
Accepted
2023-11-13 07:57:15
Documents
51
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vyne-20230930.htm   iXBRL 10-Q 827135
2 EX-31.1 vyne-20230930xexx311.htm EX-31.1 9609
3 EX-31.2 vyne-20230930xexx312.htm EX-31.2 9603
4 EX-32.1 vyne-20230930xexx321.htm EX-32.1 5252
5 EX-32.2 vyne-20230930xexx322.htm EX-32.2 5247
  Complete submission text file 0001628280-23-038414.txt   4341619

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20230930.xsd EX-101.SCH 33131
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20230930_cal.xml EX-101.CAL 48854
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20230930_def.xml EX-101.DEF 180449
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20230930_lab.xml EX-101.LAB 416140
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20230930_pre.xml EX-101.PRE 283282
45 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20230930_htm.xml XML 431858
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 231395189
SIC: 2834 Pharmaceutical Preparations